New Clues Into a Serious Neurodegenerative Disease, Frontotemporal Dementia

A genetic form of frontotemporal dementia is associated with abnormal lipid accumulation in the brain fueled by disrupted cell metabolism. The findings could pave the way for new targeted therapies for FTD.

Related Keywords

California ,United States ,Canada ,San Francisco ,Canadian ,William Seeley ,Robert Farese Jr ,Shubham Singh ,Salvatore Spina ,Tobias Walther ,Alexander Fischer ,Pedro Malia ,Geetika Aggarwal ,Lea Grinberg ,Alissa Nana ,Joao Paulo ,Michal Surma ,Sebastian Boland ,Ekaterina Pesheva ,Ruth Richards ,Wade Harper ,Lipotype Gmb ,Sharan Swarup ,Andrew Nguyen ,Yohannes Ambaw ,Christian Klose ,University Of California ,Nature Communications ,Harvard Chan School ,Department Of Cell Biology ,National Institutes Of Health ,Interline Therapeutics Inc ,Harvard Medical School ,Antora Bio Inc ,Canadian Institutes Of Health Research ,Walther ,Saint Louis University School Of Medicine ,Farese Walther Lab ,Blavatnik Institute ,Caraway Therapeutics Inc ,Howard Hughes Medical Institute ,Chan School ,Public Health ,Natalie Vallee Professor ,Molecular Pathology ,Cell Biology ,Walther Lab ,Saint Louis University School ,Bluefield Project ,National Institutes ,Google Ventures ,Third Rock Ventures ,Aligning Science Across Parkinson ,Canadian Institutes ,Health Research ,Howard Hughes Medical ,Caraway Therapeutics ,Interline Therapeutics ,Robert Farese ,Antora Bio ,Neuroscience Newsletter ,